Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 608

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 608
---
anche B Warrants (or the resale of shares of Common Stock underlying the New Tranche B Warrants); provided, however, the New Tranche B Warrants may only be exercised on a cashless basis if there is no registration statement to cover the issuance of the shares of Common Stock underlying the New Tranche B Warrants or the resale of such shares. The New Tranche B Warrants shall have an expiration date of October 8, 2029. The Company recognized a loss in the amount of $ 1.1million in relation to this exchange transaction. As of September 30, 2025, there were 500,000New Tranche B Warrants outstanding. The terms of the New Tranche B Warrants are generally identical to the terms of the Existing Tranche B Warrants, other than with respect to the number of shares issuable upon exercise thereof and the Exercise Price and certain other matters. The Exercise Price of the New Tranche B Warrants is subject to adjustment for any stock split, stock dividend, stock combination, recapitalization or similar event. The Exercise Price is also subject to full-ratchet adjustment (down to the Exercise Price Floor (as defined below)) in connection with a subsequent offering at a per share price less than the exercise price then in effect. The New Tranche B Warrants also permit a voluntary adjustment to the Exercise Price, subject to certain conditions set forth therein, including compliance with the Nasdaq Listing Rules and having obtained the prior written consent of the required holders as described therein. The Exercise Price cannot be lower than $ 36.40per share (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events, the “Exercise Price Floor”), unless shareholder approval is obtained to allow the New Tranche B Warrants to be exercised at a price lower than the Exercise Price Floor in accordance with the Nasdaq Listing Rules. The Company is under no obligation to seek or obtain such shareholder approval. F-87

The following table provides a summary of the changes in the balance and the estimated fair value of the Tranche B Notes (in thousands):

|                                                                                                                                     |     | September 30,2025 |         |   |
|:------------------------------------------------------------------------------------------------------------------------------------|:----|:------------------|--------:|:--|
| Ending Balance as of December 31, 2024                                                                                              |     | $                 |  23,560 |   |
| Repayment of Tranche B Notes principal and interest                                                                                 |     |